COG ACCL1033 - Assessing Compliance With Mercaptopurine Treatment in Younger Patients With Acute Lymphoblastic Leukemia in First Remission

Objective

This randomized phase III trial studies compliance to a mercaptopurine treatment intervention compared to standard of care in younger patients with acute lymphoblastic leukemia in remission. Assessing ways to help patients who have acute lymphoblastic leukemia to take their medications as prescribed may help them in taking their medications more consistently and may improve treatment outcomes.

https://clinicaltrials.gov/ct2/show/NCT01503632?term=accl1033&rank=1

Location:

Essentia Health Duluth

Diclosures:

None.

For more information about a financial conflict of interest (FCOI) or to review the Essentia Health FCOI policy, click here.

Last Updated: 05/12/2015F

Research Study Categories

  • Pediatric Studies

Specialty

  • Cancer
  • Cancer Control/Prevention
  • Leukemia